{
  "slug": "pando-bioscience",
  "name": "Pando Bioscience",
  "yc_id": 28425,
  "batch": "Winter 2023",
  "website": "https://pando.bio/",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:23:41.689391",
    "website": "https://pando.bio/",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 4727.56,
      "final_url": "https://www.pando.bio/",
      "redirected": true,
      "checked_at": "2025-10-17T01:23:46.416977"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "pando.bio",
      "error": "Whois command returned no output"
    },
    "social_links": {
      "twitter": null,
      "linkedin": "https://www.linkedin.com/company/pando-bioscience/",
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": false,
      "x_frame_options": false,
      "x_content_type_options": true,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 33,
      "server": "Framer/56b5dd6"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:40:43.112152",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0-claude",
    "model_used": "claude-sonnet-4-20250514",
    "enriched_at": "2025-10-17T10:52:25.959698",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "growing",
      "key_trends": [
        "AI-driven drug discovery acceleration",
        "Synthetic biology industrialization",
        "Pharmaceutical cost reduction pressure"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Proprietary ultra-high-throughput screening platform combined with generative AI creates data flywheel effect",
      "differentiation": "1000x more enzyme screening capacity at 75% faster speed and 80% lower cost than traditional methods",
      "competitive_advantages": [
        "Superior screening throughput",
        "AI-driven optimization across multiple properties",
        "Cost-effective platform"
      ],
      "competitive_vulnerabilities": [
        "Early stage technology validation",
        "Dependence on AI model accuracy"
      ]
    },
    "business_model": {
      "revenue_model": "B2B services/licensing",
      "scalability": "high",
      "capital_intensity": "medium"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Strong value proposition metrics",
        "Large addressable pharmaceutical market"
      ],
      "growth_bottlenecks": [
        "Customer acquisition in conservative pharma industry",
        "Proving platform reliability at scale"
      ]
    },
    "risk_analysis": {
      "market_risk": "low",
      "technology_risk": "medium",
      "execution_risk": "medium",
      "overall_risk_score": 6,
      "key_risks": [
        "Technology validation challenges",
        "Long pharmaceutical sales cycles",
        "Competition from established biotech companies"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Massive efficiency gains over traditional methods",
        "Large and growing market",
        "Strong technical differentiation"
      ],
      "concerns": [
        "Early stage with unproven commercial traction",
        "Complex regulatory environment"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Zymergen",
        "Ginkgo Bioworks"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure pilot partnerships with mid-tier pharma companies",
        "Publish validation studies to build credibility"
      ],
      "expansion_opportunities": [
        "Adjacent markets like agriculture and chemicals",
        "Platform licensing to biotech companies"
      ]
    },
    "tokens_used": {
      "input": 707,
      "output": 542,
      "total": 1249,
      "estimated_cost": 0.010251
    },
    "status": "success"
  },
  "phase8_complete": true
}